<DOC>
	<DOC>NCT02242838</DOC>
	<brief_summary>The primary objective of this survey is to prospectively investigate safety and efficacy in patients with hypertension treated with telmisartan in proper use in medical practice over a long period</brief_summary>
	<brief_title>Post-Marketing Surveillance of MicardisÂ® (Telmisartan) in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Patients with hypertension Patients with the following conditions Patients with a history of hypersensitivity of this product Women in pregnancy (included the possibility of pregnancy) Patients with severe biliary obstructive disorders or severe hepatic insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>